RhythmScience partners with QT Medical and announces new product reveal at Heart Rhythm Society 2022

SAN FRANCISCO, Calif. – Healthcare technology innovator RhythmScience has announced a new partnership with QT Medical that transforms EKG monitoring for cardiac clinics. Harnessing the power of QT Medical’s market-leading EKG devices, RhythmScience now offers a direct electrocardiogram integration via its Rhythm360 remote patient and device monitoring platform. 

Utilizing hospital-grade, 12-lead EKGs from QT Medical alongside existing physiologic and CIED monitoring metrics, the Rhythm360 platform offers unparalleled insights into cardiology patient data. The new EKG integration allows direct monitoring of the heart’s electrical signals in a home setting, providing more patients with convenient access to critical diagnostics and offering new insights to clinicians for better care outcomes.

“Transforming cardiology care drives everything we do at RhythmScience, and our new EKG integration is yet another piece of that transformation - one that brings significant benefits to patient populations and to providers,” said Shawn Kumar, RhythmScience founder and CEO. “The ability to run diagnostics such as EKG, blood pressure and weight in the home setting, alongside remote cardiac device monitoring and bidirectional EHR integration, opens up new doors for patient care.”

For existing Rhythm360 clinics, the 12-lead EKG device can be ordered through a provider's Rhythm360 portal, and is then mailed directly to a patient – saving time and additional trips to and from the clinic or hospital. Diagnostic data is wirelessly transmitted to the Rhythm360 portal without any additional patient interaction, allowing physicians to access results on a computer, tablet, smartphone, or other connected device, alongside additional patient reports and data to help drive better clinical decisions. 

“This is just one of several new innovations on the horizon for the Rhythm360 platform,” said Kumar. “We’re proud to be on the forefront of revolutionizing what remote monitoring means in the cardiology space - with much more to come.”

In addition to the QT Medical partnership, RhythmScience plans to announce a new product offering during the Heart Rhythm 2022 event being held in San Francisco this week. They can be found at booth #2141.

 Healthcare technology innovator RhythmScience has announced a new partnership with QT Medical that transforms EKG monitoring for cardiac clinics. Harnessing the power of QT Medical’s market-leading EKG devices, RhythmScience now offers a direct electrocardiogram integration via its Rhythm360 remote patient and device monitoring platform. 

About RhythmScience: RhythmScience builds human-centric healthcare technology.  We create cardiac disease management automation software utilizing implanted and wearable sensor data to improve patient outcomes while increasing revenue collection for providers. 

Learn more about RhythmScience: https://www.rhythm360.io/

Learn more about Heart Rhythm 2022: https://www.hrsonline.org/latest-from-hrs/heart-rhythm-2022

Learn more about QT Medical: https://www.qtmedical.com

‍